{"organizations": [], "uuid": "dedb4f744b657ab2a953332c52a0caa56c3a4726", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-biocryst-pharma-and-idera-pharma-s/brief-biocryst-pharma-and-idera-pharma-sign-merger-agreement-to-form-new-company-idUSFWN1PH0OA", "country": "US", "domain_rank": 408, "title": "BRIEF-Biocryst Pharma And Idera Pharma Sign Merger Agreement To Form New Company", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-22T15:54:00.000+02:00", "replies_count": 0, "uuid": "dedb4f744b657ab2a953332c52a0caa56c3a4726"}, "author": "", "url": "https://www.reuters.com/article/brief-biocryst-pharma-and-idera-pharma-s/brief-biocryst-pharma-and-idera-pharma-sign-merger-agreement-to-form-new-company-idUSFWN1PH0OA", "ord_in_thread": 0, "title": "BRIEF-Biocryst Pharma And Idera Pharma Sign Merger Agreement To Form New Company", "locations": [], "entities": {"persons": [{"name": "robert ingram", "sentiment": "none"}, {"name": "vincent milano", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-biocryst pharma and idera pharma", "sentiment": "negative"}, {"name": "brief-biocryst pharma and idera pharma sign merger agreement to form new company", "sentiment": "negative"}, {"name": "idera pharmaceuticals inc", "sentiment": "none"}, {"name": "biocryst pharmaceuticals inc", "sentiment": "none"}, {"name": "to form new company reuters staff", "sentiment": "none"}, {"name": "biocryst", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 22, 2018 / 1:55 PM / in 6 minutes BRIEF-Biocryst Pharma And Idera Pharma Sign Merger Agreement To Form New Company Reuters Staff 2 Min Read \nJan 22 (Reuters) - Biocryst Pharmaceuticals Inc: \n* BIOCRYST PHARMACEUTICALS AND IDERA PHARMACEUTICALS ANNOUNCE MERGER TO COMBINE CAPABILITIES TO SERVE MORE PATIENTS WITH RARE DISEASES \n* IDERA PHARMACEUTICALS INC - ‍MERGER AGREEMENT HAS BEEN UNANIMOUSLY APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES​ \n* IDERA PHARMACEUTICALS INC - ROBERT INGRAM TO BE CHAIRMAN OF BOARD, VINCENT MILANO TO BE CEO OF COMBINED COMPANY \n* IDERA PHARMACEUTICALS - UNDER TERMS OF MERGER AGREEMENT, EACH SHARE OF BIOCRYST COMMON STOCK WILL BE EXCHANGED FOR 0.50 SHARES OF NEW COMPANY STOCK \n* IDERA PHARMACEUTICALS - UNDER TERMS OF MERGER AGREEMENT, EACH SHARE OF IDERA COMMON STOCK WILL BE EXCHANGED FOR 0.20 SHARES OF NEW COMPANY STOCK \n* IDERA PHARMACEUTICALS - ‍SIGNIFICANT STOCKHOLDER OF CO, BIOCRYST AGREED TO ENTER VOTING AND SUPPORT AGREEMENT AND HAS AGREED TO VOTE IN FAVOR OF DEAL​ \n* IDERA PHARMACEUTICALS INC - AFTER DEAL BIOCRYST STOCKHOLDERS WILL OWN 51.6 PERCENT OF STOCK OF COMBINED COMPANY, CO‘S STOCKHOLDERS TO OWN 48.4 PERCENT \n* IDERA PHARMACEUTICALS - COMBINED COMPANY, WHICH WILL BE RENAMED POST-CLOSING, WILL BE HEADQUARTERED AT CURRENT IDERA HEADQUARTERS \n* IDERA PHARMACEUTICALS INC - STOCK ISSUANCE IN MERGER IS EXPECTED TO BE TAX-FREE TO STOCKHOLDERS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-22T15:54:00.000+02:00", "crawled": "2018-01-22T16:03:06.022+02:00", "highlightTitle": ""}